Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Assessment of clinical benefit, cost and uptake of biosim... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China
0
Authors
Xin Du
9 more
Xin Du
•
Xingxian Luo
7 more
•
Yi Zhang
Published
December 4, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Frontiers in Public Health
Topics
Medicine
Immunology
Internal Medicine
Rheumatology
Infectious Diseases
Show all topics
DOI
10.3389/fpubh.2024.1476213
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Frontiers in Public Health
Topics
Medicine
Immunology
Internal Medicine
Rheumatology
Infectious Diseases
Show all topics
DOI
10.3389/fpubh.2024.1476213
License
CC-BY
